Minghe Luo | Natural Products Biosynthesis | Editorial Board Member

Published on by Biotechnology Scientist

Assoc. Prof. Dr. Minghe Luo | Natural Products Biosynthesis | Editorial Board Member

Associate Professor at Chongqing University of Technology | China

Assoc. Prof. Dr. Minghe Luo is a highly accomplished researcher specializing in natural products chemistry, microbial biosynthesis, medicinal chemistry, and marine-derived bioactive compounds, with a strong scientific record demonstrated by 826 citations, 36 peer-reviewed publications, and an h-index of 18 on Scopus. His research integrates natural product discovery, biosynthetic pathway elucidation, enzymatic function analysis, and bioactivity evaluation, contributing significantly to the development of antibacterial agents, hepatoprotective molecules, siderophores, diketopiperazines, and structurally diverse marine fungal metabolites. Dr. Luo has made major advancements in understanding complex biosynthetic mechanisms, including cytochrome P450–mediated oxidation, polyketide assembly, and enzyme-catalyzed tailoring reactions, highlighted in high-impact journals such as Angewandte Chemie International Edition, Nature Communications, Chemical Engineering Journal, Journal of Natural Products, and Organic Letters. His work also includes innovative studies on deep-sea fungi, Streptomyces species, and marine actinomycetes, leading to the discovery of new anthraquinones, nucleoside antibiotics, and novel polyketide derivatives. As both first author and corresponding author on multiple publications, Dr. Luo has demonstrated strong scientific leadership, editorial judgment, and expertise in guiding research from discovery to mechanistic analysis. He has contributed to several nationally funded research projects and has led investigations into antibacterial natural products and biosynthetic gene clusters, reinforcing his role as an influential scientist in pharmaceutical biotechnology. Dr. Luo’s extensive publication record, multidisciplinary expertise, and consistent scientific impact make him exceptionally well-suited for an Editorial Board Member role in journals focused on natural products, biosynthesis, pharmaceutical chemistry, and microbial biotechnology.

Profiles : Scopus | ORCID | Google Scholar

Featured Publications

Ma, J., Wang, Z., Huang, H., Luo, M., Zuo, D., Wang, B., Sun, A., Cheng, Y. Q., & Ju, J. (2011). Biosynthesis of himastatin: Assembly line and characterization of three cytochrome P450 enzymes involved in the post-tailoring oxidative steps. Angewandte Chemie International Edition. (Cited by: 103)

Shi, S., Zhou, M., Li, X., Hu, M., Li, C., Li, M., Sheng, F., Li, Z., Wu, G., Luo, M., Cui, H., & others. (2016). Synergistic active targeting of dually integrin αvβ3/CD44-targeted nanoparticles to B16F10 tumors located at different sites of mouse bodies. Journal of Controlled Release. (Cited by: 92)

Huang, H., Wang, F., Luo, M., Chen, Y., Song, Y., Zhang, W., Zhang, S., & Ju, J. (2012). Halogenated anthraquinones from the marine-derived fungus Aspergillus sp. SCSIO F063. Journal of Natural Products. (Cited by: 88)

Li, Y., Shi, S., Ming, Y., Wang, L., Li, C., Luo, M., Li, Z., Li, B., & Chen, J. (2018). Specific cancer stem cell therapy by albumin nanoparticles functionalized with CD44-mediated targeting. Journal of Nanobiotechnology. (Cited by: 72)

Ming, Y., Li, Y., Xing, H., Luo, M., Li, Z., Chen, J., Mo, J., & Shi, S. (2017). Circulating tumor cells: From theory to nanotechnology-based detection. Frontiers in Pharmacology. (Cited by: 66)